Kehry, Marilyn,King, David J.,Ling, Leona E.,Meador lll, James,Roy, Sucharita,Manning, Anthony
申请号：
AU2016211280
公开号：
AU2016211280A1
申请日:
2016.01.29
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention features antibodies that have high binding affinity to human neonatal Fc receptor (FcRn). These anti-FcRn antibodies are useful, e.g., to promote clearance of autoantibodies in a subject, to suppress antigen presentation in a subject, to block an immune response, e.g., block an immune complex-based activation of the immune response in a subject, and to treat immunological diseases (e.g., autoimmune diseases) in a subject.
